Register Login
Register to leave comments
  • News bot March 22, 2026, 8:58 a.m.

    📋 ELEDON PHARMACEUTICALS, INC. (ELDN) - Financial Results

    Filing Date: 2026-03-19

    Accepted: 2026-03-19 17:02:09

    Event Type: Financial Results

    Event Details:

    ELEDON PHARMACEUTICALS, INC. (ELDN) Reports the reporting period Financial Results ELEDON PHARMACEUTICALS, INC. (ELDN) announced its financial results for the period ending the reporting period. Key Financial Highlights:
    • Revenue: Not disclosed
    • Net Income: Not disclosed
    • EPS: (28.73
    • Cash and equivalents: 22808
      • CD40L antibody, as a potential next
      • generation immunosuppressive therapy across multiple transplantation settings,” said David
      • Alexandre C. Gros, M.D., Chief Executive Officer of Eledon. “The over 100 patients treated across our transplantation programs to date provide a growing body of evidence that reinforces our conviction that tegoprubart can address key safety and efficacy issues with current standard

    📊 Key Financial Metrics (Year-over-Year Comparison):

    Metric 2025 2024 Change ($) Change (%)
    Current Assets Prepaid Expenses Other Current Assets 2.35K 3.55K $-1.20K -33.78%
    Current Assets Operating Lease Right Of Use Assets 613.00 926.00 $-313.00 -33.80%
    Current Assets Other Assets 322.00 363.00 $-41.00 -11.29%
    Current Liabilities Accounts Payable 3.63K 5.83K $-2.21K -37.82%
    Operating Expenses Other Income Net 4.22K 3.92K $296.00 +7.54%
    Operating Expenses Net Loss 45.62K 36.18K $9.43K +26.07%
    Prepaid Expenses and Other Current Assets 2.35K 3.55K $-1.20K -33.78%
    Other Assets 322.00 363.00 $-41.00 -11.29%
    Accounts Payable 3.63K 5.83K $-2.21K -37.82%
    Other Income, Net 4.22K 3.92K $296.00 +7.54%
    Net Loss 45.62K 36.18K $9.43K +26.07%

    💼 Business Developments:

    • Partnership: Not available
    • Acquisition: Not available
    • Licensing: Not available
    • Regulatory Approval
    • Executive Changes: Not available

    Structured Data:

    • Company Name: ELEDON PHARMACEUTICALS, INC.
    • Ticker Symbol: ELDN

Search

News categories